Holen Sie sich die Stockscreener-App
0.1841
6.97%
-0.0138
Handel nachbörslich:
.19
0.0059
+3.20%
Schlusskurs vom Vortag:
$0.1979
Offen:
$0.205
24-Stunden-Volumen:
840.88K
Relative Volume:
0.08
Marktkapitalisierung:
$2.98M
Einnahmen:
$7,500
Nettoeinkommen (Verlust:
$-10.96M
KGV:
-0.0802
EPS:
-2.2943
Netto-Cashflow:
$-11.41M
1W Leistung:
-13.28%
1M Leistung:
+2.28%
6M Leistung:
-38.65%
1J Leistung:
-31.71%
1-Tages-Spanne:
$0.178
$0.205
1-Wochen-Bereich:
$0.178
$0.2375
52-Wochen-Spanne:
$0.10
$1.40
Azitra Inc Stock (AZTR) Company Profile
Firmenname
Azitra Inc
Sektor
Branche
Telefon
203 646 6446
Adresse
21 Business Park Drive, Branford
Compare AZTR vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AZTR
Azitra Inc
|
0.1841 | 3.20M | 7,500 | -10.96M | -11.41M | -2.2943 |
VRTX
Vertex Pharmaceuticals Inc
|
453.17 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.73 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
878.49 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
281.90 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
156.58 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Azitra Inc Aktie (AZTR) Neueste Nachrichten
AZTR Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin, Stock DeclinesEarnings Yield Analysis - newsline.com
AZTR Q1 2026 Earnings: Massive EPS Miss Highlights Operational ChallengesAnnual Financial Report - newsline.com
Why Is AZTR Stock Rising Today? - Stocktwits
Azitra, Inc. Announces Q3 2024 Financial Results and Provides Bu - GuruFocus
Azitra Adjourns 2026 Annual Meeting for Lack of Quorum - TipRanks
Azitra (AZTR) delays 2026 annual meeting after low shareholder turnout - Stock Titan
Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting - Nasdaq
[EFFECT] Azitra, Inc. SEC Filing - Stock Titan
Azitra Inc (AZTR) Slips 5% as Stock Tests Key Support Near $0.21Counter Trend Trade - newsline.com
Azitra Inc (AZTR) Surges 12%: Small-Cap Biotech Breaks Above SupportHead and Shoulders - thelegaladvocate.com
Azitra Inc Q1 2026 Earnings: EPS Misses Estimates by Wide Margin; Stock Surges Amid No Revenue Reported - The Legal Advocate
Azitra Inc (AZTR) Surges 12%: Testing Key Resistance at $0.24Wyckoff Accumulation - The Legal Advocate
AZTR Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin as Pre-Revenue Biotech Advances Pipeline - newsline.com
Azitra Adjusts 2026 Annual Shareholders Meeting Schedule - The Globe and Mail
Azitra to Adjourn and Reconvene 2026 Annual Meeting to Allow Additional Proxy Voting Time - Minichart
Azitra Inc (AZTR) Slides to $0.21: Navigating Key Support at $0.20Fibonacci Time Zone - The Legal Advocate
Azitra Inc (AZTR) Tests Support Level as Stock Declines SlightlyVolume Rate Change - The Legal Advocate
Azitra announces intention to adjourn annual meeting and reconvene annual meeting - marketscreener.com
Azitra to adjourn June 4 annual meeting; reconvene virtually June 15 to allow additional proxy mailing time - TradingView
Azitra (NYSE: AZTR) sets June 15 date to reconvene 2026 virtual annual meeting - Stock Titan
Proxy mailing delay pushes Azitra’s virtual shareholder meeting - Stock Titan
Azitra Q1 2026 Earnings: Significant EPS Miss Amid Development Stage OperationsQuarterly Profit Report - newsline.com
Azitra Inc Financial Disclosures & SEC Filings - TradingView
Azitra Inc (AZTR) Q1 2026 Earnings: Wider-Than-Expected Loss Amid Pre-Revenue StageProfit Recovery Report - Newser
AZTR Q1 2026 Earnings: Significant EPS Miss and Stock Decline Amid Pre-Revenue StageEarnings Preview - The Legal Advocate
AZTR Q1 2026 Earnings: Significant EPS Miss Amidst Early-Stage DevelopmentShort-Term Outlook - Newser
AZTR Q1 2026 Earnings: Massive EPS Miss Exceeds Expectations as Stock Declines Nearly 4%Dividend Increase Stocks - The Legal Advocate
Azitra (NYSE: AZTR) S-1 shows massive resale dilution and risks - Stock Titan
Azitra (AZTR) Stock: Down -1.58%, Support Test at $0.18 2026-05-19Free Stock Community - Newser
AZTR SEC FilingsAzitra Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Azitra (AZTR) Stock Analysis: Falls -2.40%, Watching $0.20 2026-05-14Profit Surge - newser.com
Azitra 1Q Loss/Shr 25c >AZTR - Moomoo
Branford biotech Azitra expands into consumer skin-care market - Hartford Business Journal
Azitra, Inc. Q1 2024 Financial Report: Operating Expenses, Net Loss, and Key Disclosures - Minichart
Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates - PR Newswire
Azitra, Inc. Announces Q1 2026 Financial Results and Pipeline Milestones for Biotherapeutics and Cosmeceuticals - Minichart
Azitra (NYSE: AZTR) widens Q1 loss but lifts cash and equity via new financings - Stock Titan
Azitra reports Q1 2026 net loss $3.9M, cash $10.1M; advances ATR-12, ATR-04 trials - TradingView
Azitra, Inc. 1Q 2026: Net loss $(3.93M), EPS $(0.25) — 10-Q Summary - TradingView
Azitra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Azitra (NYSE: AZTR) widens Q1 2026 loss but strengthens cash and pipeline - Stock Titan
MSN Money - MSN
Number of shareholders of Azitra Inc – AMEX:AZTR - TradingView
Azitra (NYSE American: AZTR) seeks OK for big share increase and reverse split - Stock Titan
[ARS] Azitra, Inc. SEC Filing - Stock Titan
Finanzdaten der Azitra Inc-Aktie (AZTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.27%
1.43%
Kapitalisierung:
|
Volumen (24h):